These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1876075)

  • 21. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress report from the NIDA Addiction Research Center, Baltimore, Maryland.
    Jasinski DR; Boren JJ; Henningfield JE; Johnson RE; Lange WR; Lukas SE
    NIDA Res Monogr; 1984 Mar; 49():69-76. PubMed ID: 6148697
    [No Abstract]   [Full Text] [Related]  

  • 24. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.
    Lintzeris N; Mitchell TB; Bond AJ; Nestor L; Strang J
    Drug Alcohol Depend; 2007 Dec; 91(2-3):187-94. PubMed ID: 17624687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ambulatory opiate withdrawal].
    Broers B; Voegeli JP
    Rev Med Suisse Romande; 1998 Sep; 118(9):743-6. PubMed ID: 9810184
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects.
    De S; Jain R; Ray R; Dhawan A; Varghese ST
    Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid detoxification using high doses of buprenorphine in 24 hours: a randomized, double blind, controlled clinical trial.
    Assadi SM; Hafezi M; Mokri A; Razzaghi EM; Ghaeli P
    J Subst Abuse Treat; 2004 Jul; 27(1):75-82. PubMed ID: 15223097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reply to letter from Margaret Stark and Guy Norfolk about the management of opiate addicts in police custody.
    Davison S; Gossop M
    Med Sci Law; 2001 Oct; 41(4):356. PubMed ID: 11693234
    [No Abstract]   [Full Text] [Related]  

  • 31. Induction of patients with moderately severe methadone dependence onto buprenorphine.
    Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
    Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of buprenorphine in methadone-dependent volunteers.
    Strain EC; Bigelow GE; Preston KL; Liebson I
    NIDA Res Monogr; 1990; 105():584. PubMed ID: 1715035
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of buspirone in the treatment of opioid withdrawal.
    Buydens-Branchey L; Branchey M; Reel-Brander C
    J Clin Psychopharmacol; 2005 Jun; 25(3):230-6. PubMed ID: 15876901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ethnicity on low-dose opiate stabilization.
    Kosten TR; Rayford BS
    J Subst Abuse Treat; 1995; 12(2):111-6. PubMed ID: 7623388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The processing of automatic thoughts of drug use and craving in opiate-dependent individuals.
    Weinstein AM; Feldtkeller BT; Law F; Myles J; Nutt DJ
    Exp Clin Psychopharmacol; 2000 Nov; 8(4):549-53. PubMed ID: 11127426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient perspectives of opiate withdrawal.
    Cohen AJ; Klett CJ; Ling W
    Drug Alcohol Depend; 1983 Oct; 12(2):167-72. PubMed ID: 6653388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Clinical Opiate Withdrawal Scale (COWS).
    Wesson DR; Ling W
    J Psychoactive Drugs; 2003; 35(2):253-9. PubMed ID: 12924748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditioned tolerance in human opiate addicts.
    Ehrman R; Ternes J; O'Brien CP; McLellan AT
    Psychopharmacology (Berl); 1992; 108(1-2):218-24. PubMed ID: 1384078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.